Filteren op Last updated date SelectNaVoorFrom - To Date Einddatum Deze week Deze maand Afgelopen week Afgelopen maand Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Laat dit veld leeg Filter Resultaten (3839) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Laat dit veld leeg Regulatory information – 1.7% and 1.6% increase of pharmacovigilance fees from 1 November 2020 4 november 2020NewsHumanFeesPharmacovigilance Extra transparency measures for COVID-19 vaccines and therapeutics 30 oktober 2020NewsHumanCOVID-19 Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26-29 October 2020 30 oktober 2020NewsHumanPharmacovigilanceReferrals Regulatory update - EMA encourages companies to submit type I variations for 2020 by end of November 29 oktober 2020NewsHumanVeterinaryRegulatory and procedural guidance EMA closed 2 November 2020 29 oktober 2020NewsCorporateCOVID-19 Strengthening global collaboration on COVID-19 real-world evidence and observational studies 23 oktober 2020NewsHumanCOVID-19 10th ESVAC report shows continued decrease in sales of veterinary antibiotics 21 oktober 2020NewsVeterinaryData on medicinesMedicines EMA virtual conference: 25 years of advancing public and animal health 19 oktober 2020NewsHumanVeterinaryHerbalCorporate First long-acting injectable antiretroviral therapy for HIV recommended for approval 16 oktober 2020NewsHumanMedicines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 October 2020 16 oktober 2020NewsHumanGeneric and hybrid medicinesMedicinesReferrals 1 … 78 79 80 81 82 Page 82 of 384 83 84 85 86 … 384
Regulatory information – 1.7% and 1.6% increase of pharmacovigilance fees from 1 November 2020 4 november 2020NewsHumanFeesPharmacovigilance
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26-29 October 2020 30 oktober 2020NewsHumanPharmacovigilanceReferrals
Regulatory update - EMA encourages companies to submit type I variations for 2020 by end of November 29 oktober 2020NewsHumanVeterinaryRegulatory and procedural guidance
Strengthening global collaboration on COVID-19 real-world evidence and observational studies 23 oktober 2020NewsHumanCOVID-19
10th ESVAC report shows continued decrease in sales of veterinary antibiotics 21 oktober 2020NewsVeterinaryData on medicinesMedicines
EMA virtual conference: 25 years of advancing public and animal health 19 oktober 2020NewsHumanVeterinaryHerbalCorporate
First long-acting injectable antiretroviral therapy for HIV recommended for approval 16 oktober 2020NewsHumanMedicines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 October 2020 16 oktober 2020NewsHumanGeneric and hybrid medicinesMedicinesReferrals